CKD Bio Corp. (063160.KS) KSC

21,000.00

-200(-0.94%)

Updated at February 20 03:30PM

Currency In KRW

Valuation

Market Cap111.7B
Enterprise Value111.7B
P/E Ratio-39.91
PEG Ratio0.1
Price/Sales Ratio0.72
Price/Book Ratio0.9
Enterprise/Revenue1.59
Enterprise/EBITDA25.21

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.02
Operating Margin0.02

Management Effectiveness

Return On Assets-0.01
Return On Equity-0.02

Income Statement

Revenue160.07B
Revenue/Share29,159.53
Gross Profit0
EBITDA3.61B
Net Income-2.89B
Diluted EPS-526.16

Balance Sheet

Total Cash1.04B
Total Cash/Share189.58
Total Debt139.82B
Total Debt/Equity1.09
Current Ratio0.92
Book Value Per Share23,439.78

Price History

52-Week Change0.96
52-Week High27,650
52-Week Low19,060
Moving Average 50 Days20,817.6
Moving Average 200 Days22,208.9

Statistics

Average Volume53,955
Shares Outstanding5.49M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.19
Last Split Factor21:20
Last Split DateDecember 27, 2019